Curis (CRIS) Other Accumulated Expenses (2011 - 2016)
Curis (CRIS) reported Other Accumulated Expenses of $226000.0 for Q2 2016, up 17.92% on a YoY basis from $191659.0 in Q3 2015, and up 17.61% quarter-over-quarter from $192164.0 in Q1 2016.
Curis (CRIS) Other Accumulated Expenses (2011 - 2016) Analysis & Trends
Curis has reported Other Accumulated Expenses for 6 years, with the latest figure at $226000.0 in Q2 2016.
- For the quarter ending Q2 2016, Other Accumulated Expenses rose 17.92% year-over-year to $226000.0; the trailing twelve-month figure through Jun 2016 stood at $226000.0 (up 17.92% YoY), and the FY2015 full-year result was $249000.0, up 17.15% from the prior year.
- Other Accumulated Expenses for Q2 2016 stood at $226000.0, up from $192164.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $249000.0 in Q4 2015, with the low at $115518.0 in Q2 2012.
- Historically, Other Accumulated Expenses has averaged $183073.9 across 5 years, with a median of $188862.0 in 2015.
- Annual changes were most pronounced in 2013 — Other Accumulated Expenses surged 86.06% — and 2014, when it decreased 22.71%.
- Curis' Other Accumulated Expenses stood at $143851.0 in 2012, then climbed by 24.01% to $178390.0 in 2013, then rose by 19.15% to $212548.0 in 2014, then rose by 17.15% to $249000.0 in 2015, then declined by 9.24% to $226000.0 in 2016.
- The last three Other Accumulated Expenses figures came in at $226000.0 (Q2 2016), $192164.0 (Q1 2016), and $249000.0 (Q4 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 226,000.00 |
| Mar 31, 2016 | 192,164.00 |
| Dec 31, 2015 | 249,000.00 |
| Sep 30, 2015 | 186,670.00 |
| Jun 30, 2015 | 191,659.00 |
| Mar 31, 2015 | 188,862.00 |
| Dec 31, 2014 | 212,548.00 |
| Sep 30, 2014 | 195,116.00 |
| Jun 30, 2014 | 166,116.00 |
| Mar 31, 2014 | 207,022.00 |
| Dec 31, 2013 | 178,390.00 |
| Sep 30, 2013 | 134,527.00 |
| Jun 30, 2013 | 214,937.00 |
| Mar 31, 2013 | 160,020.00 |
| Dec 31, 2012 | 143,851.00 |
| Sep 30, 2012 | 149,857.00 |
| Jun 30, 2012 | 115,518.00 |
| Dec 31, 2011 | 166,037.00 |